You are here: Abbott Northwestern Hospital > Medication Protocols

Print

Send to a Friend

Enoxaparin (Lovenox^®-low molecular weight heparin) Protocols

File	Description
Prophylactic Protocol enoxprophinit.vb-link.vb enoxprophadjust.vb-link.vb Therapeutic Protocol enoxtherinit.vb-link.vb enoxtheradjust.vb-link.vb	These Visual Basic files will allow you to store the Enoxaparin (Lovenox®-low molecular weight heparin) Protocols on your Pocket PC. The prophylactic (enoxproph) protocol targets a lower antifactor Xa activity range than does the therapeutic (enoxther) protocol. Each protocol consists of two files: an "initiate" (init.vb) file and an "adjust" (adjust.vb) file. The enoxprophinit.vb and enoxtherinit.vb files are used for the initiation of subcutaneous enoxaparin therapy in a patient. The enoxprophadjust.vb and enoxtheradjust.vb files are used thereafter to adjust the enoxaparin subcutaneous dose based on antifactor Xa activity results in a patient receiving enoxaparin.
Prophylactic Protocol enoxaparinPROPHY,SQ_female initiate.xls enoxaparinPROPHY,SQ_male initiate.xls enoxaparinPROPHY,SQ_adjust 1.xls enoxaparinPROPHY,SQ_adjust 2.xls Therapeutic Protocol enoxaparinTHERA,SQ_female initiate.xls enoxaparinTHERA,SQ_male initiate.xls enoxaparinTHERA,SQ_adjust 1.xls enoxaparinTHERA,SQ_adjust 2.xls enoxaparinTHERA,SQ_adjust 3.xls	The Enoxaparin (Lovenox®-low molecular weight heparin) Protocols consist of several files each; 4 for the prophylactic (PROPHY, SQ) protocol and 4 for the therapeutic (THERA, SQ) protocol: The prophylactic (PROPHY, SQ) protocol targets a lower antifactor Xa activity range than does the therapeutic (THERA, SQ) protocol. The enoxaparinXXXXX, SQ_female initiate.xls and enoxaparinXXXXX,SQ_male initiate.xls files are used for the initiation of subcutaneous enoxaparin therapy and are identical with the exception that patient gender is "defaulted" into the appropriate spreadsheet. This saves the user a few keystrokes. The enoxaparinXXXXX, SQ_adjust#.xls files are used subsequently for all patients, regardless of gender, to adjust the enoxaparin dose based on antifactor Xa activity results from a patient receiving enoxaparin. The adjust 1.xls files are used to interpret an antifactor Xa result obtained after administration of the first dose of enoxaparin. The adjust 2.xls files are used to interpret an antifactor Xa result obtained after administration of the second dose of enoxaparin, and in the case of the prophylactic protocol (PROPHY, SQ) after all subsequent enoxaparin doses. When the therapeutic protocol (THERA, SQ) is used, the adjust 3.xls file is used to interpret an antifactor Xa result obtained after administration of the third and all subsequent doses of enoxaparin.
LMW Monitoring Flow Sheet.xls	Monitoring Flow Sheet This monitoring flow sheet may be used to track and document patient demographics, enoxaparin doses, and antifactor Xa results.
SQ injection.doc CareNotes Enoxaparin.doc InjectionSites.pdf	Patient Education Materials The SQ injection.doc outlines the step-by-step procedure for patient self-injection of subcutaneous enoxaparin. Patient information about the purpose, use, storage, drug interactions, and side effects of enoxaparin are found in CareNotes Enoxaparin.doc (Thomson MICROMEDEX. All rights reserved. The CareNotes(TM) System). A SQ injection site rotation record is found in InjectionSites.pdf.

 

First published: 09/01/2004
Last updated: 03/16/2007

Reviewed by: Shelley Shepherd, PharmD, MS; Terry Rosborough, MD